Editor’s note: The Covid-19 Vaccine Frequently Asked Questions page has been retired. Updated information regarding Covid-19 vaccination may be found at the NEJM Covid-19 Vaccine Resource Center.

The FDA chief has also expressed concerns about the lack of data supporting Novavax’s COVID vaccine, calling for more studies into its effectiveness before approving it. "The big Novavax 2020 ...

Kennedy and FDA Commissioner Marty Makary’s approach to assessing vaccines could put Covid boosters out of reach.

Despite the global success of COVID-19 vaccination campaigns, concerns remain ... at the Oxford Vaccine Group (OVG), led the study. He said: "These results confirm the efficacy of vaccination ...

A pharmacy in New York City advertises the coronavirus vaccine on March 11 ... it was business as usual. Among the issues discussed was whether to change the coronavirus booster from a universal ...

These designed proteins enable early assessment of vaccine efficacy before such variants ... breakthrough infections observed during the coronavirus disease 2019 (COVID-19) pandemic, caused ...

Brazilian health authorities Thursday launched a campaign explaining the proper use and handling of the Janssen COVID-19 vaccine and the number of booster doses recommended for this specific drug.

The mRNA Covid vaccines were designed so that this ... more onerous to test by bringing up these sort of false safety concerns or false efficacy concerns,” Offit said. Dr. Sean O’Leary ...

Outbreaks of COVID-19 ... previous strains—has raised concerns across the world, highlighting the urgent need for an effective, safe, and multivalent vaccine. LC16m8 is an attenuated vaccinia ...